News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,638 Results
Type
Article (50409)
Company Profile (315)
Press Release (673914)
Section
Business (213355)
Career Advice (2104)
Deals (36787)
Drug Delivery (88)
Drug Development (83595)
Employer Resources (168)
FDA (16847)
Job Trends (15783)
News (360463)
Policy (34921)
Tag
Academia (2781)
Africa (796)
Alliances (51590)
Alzheimer's disease (1194)
Approvals (16770)
Arizona (184)
Artificial intelligence (78)
Asia (40411)
Australia (6671)
Bankruptcy (369)
Best Places to Work (11803)
Biotechnology (220)
C2C Services and Suppliers (86815)
California (1856)
Canada (919)
Cancer (480)
Career advice (1765)
Cell therapy (123)
China (149)
Clinical research (65339)
Collaboration (136)
Colorado (77)
Compensation (77)
Connecticut (76)
COVID-19 (2632)
Cystic fibrosis (72)
Data (283)
Diabetes (84)
Diagnostics (6219)
Drug pricing (69)
Earnings (86242)
Employer resources (143)
Europe (87494)
Events (115514)
Executive appointments (148)
FDA (17058)
Florida (261)
Funding (139)
Gene therapy (91)
Georgia (67)
GLP-1 (554)
Government (4590)
Healthcare (19805)
Hotbed/Location (502447)
Illinois (278)
Indiana (148)
Infectious disease (2661)
Inflammatory bowel disease (96)
Interviews (316)
IPO (16698)
Job creations (4104)
Job search strategy (1523)
Kansas (98)
Layoffs (420)
Legal (8555)
Lung cancer (111)
Manufacturing (85)
Maryland (402)
Massachusetts (1538)
Medical device (14033)
Medtech (14038)
Mergers & acquisitions (19922)
Metabolic disorders (267)
Michigan (126)
Minnesota (223)
Neuroscience (1343)
New Jersey (573)
New York (598)
NextGen Class of 2024 (6939)
Non-profit (4760)
North Carolina (638)
Northern California (819)
Obesity (161)
Ohio (106)
Opinion (191)
Patents (67)
Pennsylvania (574)
People (59200)
Pharmaceutical (68)
Phase I (20227)
Phase II (28720)
Phase III (21490)
Pipeline (105)
Postmarket research (2762)
Preclinical (8647)
Press Release (67)
Rare diseases (130)
Real estate (6357)
Recruiting (63)
Regulatory (22724)
Research institute (2479)
Resumes & cover letters (360)
South America (1185)
Southern California (747)
Startups (3880)
Texas (240)
United States (8645)
Vaccines (508)
Washington State (254)
Weight loss (144)
Date
Today (173)
Last 7 days (695)
Last 30 days (2292)
Last 365 days (38547)
2024 (26705)
2023 (41392)
2022 (52647)
2021 (57315)
2020 (56118)
2019 (49158)
2018 (37232)
2017 (34014)
2016 (34036)
2015 (40117)
2014 (33794)
2013 (29035)
2012 (31354)
2011 (32038)
2010 (30591)
724,638 Results for "ym biosciences formerly york medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
Harvard Bioscience, Inc. announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York City on June 5, 2024.
May 23, 2024
·
1 min read
Pharm Country
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
Verrica Pharmaceuticals Inc. today announced that Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City.
May 30, 2024
·
1 min read
Genetown
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14th Annual East Coast IDEAS Conference at the Jay Conference Center – Bryant Park in New York City on June 12, 2024.
June 6, 2024
·
1 min read
Business
MBX Biosciences Appoints Salomon Azoulay, M.D., as Chief Medical Officer
MBX Biosciences, Inc. today announced the appointment of Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (CMO).
June 25, 2024
·
3 min read
Biotech Bay
IGM Biosciences to Present at the 2024 Jefferies Healthcare Conference
IGM Biosciences, Inc. announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 5, 2024, at 2:30 p.m. EDT in New York.
May 29, 2024
·
1 min read
Biotech Beach
Skye Bioscience to Present at Jefferies Global Healthcare Conference
Skye Bioscience, Inc. today announced that Chief Executive Officer & Chair, Punit Dhillon, will present an overview of the company and its programs in obesity and glaucoma at the Jefferies Global Healthcare Conference being held in New York City.
June 3, 2024
·
3 min read
BioMidwest
Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
Pacira BioSciences, Inc. announced that it will participate in an analyst-led fireside chat at the 2024 Jefferies Global Healthcare Conference at 11:00 AM ET on Thursday, June 6, 2024 in New York.
May 30, 2024
·
1 min read
Biotech Beach
Aadi Bioscience to Participate in the Jefferies Healthcare Conference
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapies for cancers with alterations in the mTOR pathway, announced today participation in the Jefferies Healthcare Conference, taking place June 5-6, 2024, in New York.
May 29, 2024
·
1 min read
Biotech Beach
Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock - June 14, 2024
Avidity Biosciences, Inc. announced the pricing of an underwritten public offering of 10,550,000 shares of its common stock at a price to the public of $38.00 per share.
June 13, 2024
·
5 min read
Biotech Bay
Octave® Bioscience, Inc. Announces Publication in Nature Communications
Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.
May 29, 2024
·
5 min read
1 of 72,464
Next
